Anhui Cancer Hospital — Hefei, Anhui

Public research footprint of Anhui Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Head and Neck Squamous Cell Carcinoma · Ovarian Cancer · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Advanced Solid Tumors

Recently updated registry entries

NCT07744126 — A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of… (Not Yet Recruiting)
NCT07744698 — Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer… (Recruiting)
NCT04895358 — Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Anhui Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.